Neural control of tumor immunity
The FEBS Journal · 2024-11 · 291 (21) · 4670-4679
DOI: 10.1111/febs.17280 ↗At a glance
Übersichtsarbeit in The FEBS Journal, published online on 2024-09-20. Written by Burak Kizil and 2 co-authors. Institution: Department of Pathology and Immunology, Faculty of Medicine, University of Geneva, Switzerland. Major MEDLINE topics: Neoplasms. Cited 17 times so far (Crossref); 69 references. The full text is freely available (open access, CC BY 4.0). Funded by: ERC Consolidator, Swiss Cancer League, Geneva Cancer League.
Abstract (original language)
Communication between the nervous system and the immune system has evolved to optimally respond to potentially dangerous stimuli both from within and outside the body. Tumors pose a severe threat to an organism and current therapies are insufficient for tumor regression in the majority of cases. Studies show that tumors are innervated by peripheral nerves from the sensory, parasympathetic and sympathetic nervous systems. Interactions between cancer cells, nerves and immune cells regulate overall tumor progression. Clinical studies have indicated the potential of targeting the peripheral nervous system for promoting anti‐tumor immune responses. This view point provides an opinion on the current evidence and therapeutic potential of manipulating neuro‐immune communications in cancer.
Subjects
MeSH terms (MEDLINE)
Author keywords
Authors and institutions
- Department of Pathology and Immunology, Faculty of Medicine, University of Geneva, Switzerland.
- Geneva Center for Inflammation Research (GCIR), Geneva, Switzerland.
- Translational Research Centre in Onco-Hematology (CRTOH), Geneva, Switzerland.
- Institute of Genetics and Genomics of Geneva (iGE3), Switzerland.
- Biomedical Center, Institute for Cardiovascular Physiology and Pathophysiology, Walter Brendel-Center for Experimental Medicine, Faculty of Medicine, Ludwig-Maximilians-Universität Munich, Planegg-Martinsried, Germany.
ORCID profiles: Christoph Scheiermann
Funding
- ERC Consolidator
- Swiss Cancer League
- Geneva Cancer League
- German Research Foundation
- EU ITN
- Human Frontier Science Program
- Swiss National Science Foundation
- Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung
Cite
APA
Kizil, B., De Virgiliis, F., & Scheiermann, C. (2024). Neural control of tumor immunity. The FEBS Journal, 291(21), 4670-4679. https://doi.org/10.1111/febs.17280
Vancouver
Kizil B, De Virgiliis F, Scheiermann C. Neural control of tumor immunity. The FEBS Journal. 2024;291(21):4670-4679. doi:10.1111/febs.17280
BibTeX
@article{Kizil2024,
author = {Kizil, Burak and De Virgiliis, Francesco and Scheiermann, Christoph},
title = {Neural control of tumor immunity},
journal = {The FEBS Journal},
year = {2024},
volume = {291},
number = {21},
pages = {4670--4679},
doi = {10.1111/febs.17280}
}
EUVIMED